The initiative is calling for expressions of interest from Australian small and medium enterprises, including start-ups and research spin-offs, that are developing medical devices to prevent, diagnose, treat, or manage heart disease and complications linked to both type 1 and type 2 diabetes.
MTPConnect launches new funding push to fast-track breakthroughs in heart disease and diabetes
February 23, 2026 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Medicines Australia seeks answers on AI in HTA process
September 23, 2026 - - Latest News -
The prevention gap and inside Sally Panton's bet on cellular health
September 23, 2026 - - Latest News -
Pfizer 'deeply disappointed' in response to PBAC refusing to move on price
September 23, 2026 - - Latest News -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News -
A 'multistakeholder' reference group to shadow agreement negotiations
September 23, 2026 - -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News
